Found 0 matching trials
COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable Biliary Tract Cancer PHASE2 The study is a single-arm, phase II trial. The purpose is to investigate bo...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma NA Concurrent chemoradiotherapy(CCRT) is the principal treatment for nasophary...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia PHASE3 RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells....
Show More Location
Addenbrooke's Hospital
Learn More & Join Trial
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC PHASE3 This is a multicentric randomized phase III trial comparing intensity-modul...
Show More Location
Centre Alexis Vautrin
Learn More & Join Trial
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva PHASE2 This phase II trial studies how well radiation therapy works when given wit...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma PHASE2 The purpose of this study is to explore whether 18F-FDG PET/CT guided reduc...
Show More Location
Taizhou Central Hospital
Learn More & Join Trial
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer(Neo-Color) PHASE2 The goal of this clinical trial is to evaluate the efficacy and safety of c...
Show More Location
the Fourth Hospital of Hebei Medical University
Learn More & Join Trial
A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer PHASE2 Varian Medical Systems has recently deployed a completely novel radiation t...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer PHASE3 This phase III trial compares the addition of induction chemotherapy, with ...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy PHASE3 This prospective trial aims to enroll patients with high-risk stage III-IVA...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial